Product Image

Melatonin 0.5 mg

Pure Encapsulations
4.9
★ ★ ★ ★ ★
(91 ratings)
Melatonin 0.5 mg
Product Image
Score83
A well-focused low-dose capsule for circadian timing and sensitive users. It offers careful dosing but no sleep-maintenance technology.
How scoring works
Quantity:180 Capsule(s) • (180 servings)
Goals:
Sleep Support

Score 83

A well-focused low-dose capsule for circadian timing and sensitive users. It offers careful dosing but no sleep-maintenance technology.
How scoring works
$31.00($0.17 per serving)
Pure Formulas
$ 31.00
Walmart
$ 31.00
Report prices

Analysis

A 0.5 mg amount allows a cautious approach to sleep timing and onset. The low dose may be especially useful for dose-sensitive users or people addressing jet lag and delayed sleep schedules.

The single active is fully disclosed and avoids unnecessary blends. Standard capsule delivery is straightforward but does not provide extended overnight release.

Low-dose control is the main advantage, not broad coverage of stress or other sleep pathways. Even at this amount, users should note any next-day drowsiness or unusual dreams before making it routine.

Who is it for
  • Melatonin-sensitive adults
  • People starting with a low dose
  • Travelers managing jet lag or schedule shifts
Best for
  • Gentle circadian timing support
  • Sleep-onset use
  • Precise low-dose routines

Pros

  • Low 0.5 mg amount
  • Fully disclosed single active
  • Long bottle supply

Cons

  • No sustained-release feature
  • Limited to the melatonin pathway
  • Capsule format is not easily divided further

Warnings

  • Melatonin can still cause drowsiness or vivid dreams in sensitive users
  • Avoid alertness-sensitive activity until personal response is clear
  • Timing matters because taking melatonin too late may affect morning alertness

Nutrient quality

90 Highest impact

The conservative melatonin amount provides precise sleep-onset support with little overdose concern. Standard capsule delivery is straightforward but offers no sleep-maintenance advantage.

.

Ingredient transparency

81 Highest impact

Active amounts and the basic serving format are clear without hidden blends. Full directions, source purity, and inactive ingredients remain incomplete.

.

Customer satisfaction

64 Moderate impact

The supplied aggregate satisfaction signal is favorable and has some support from its response volume. Specific experience details are absent, so complaint patterns and purpose fit cannot be confirmed.

.

Value for money

93 Highest impact

The dose, format, and serving value make the product competitively positioned. Only incomplete purity or excipient detail limits the comparison.

.
Report analysis

Goals

Sleep Support
Impact
Highest effect
A+ Goal FitA Strength of SupportC+ CoverageA+ Formula Quality
Melatonin · 0.5 mg

Low-dose melatonin closely matches natural circadian signaling and directly targets sleep onset. It is especially relevant for jet lag or a delayed sleep schedule rather than every cause of poor sleep.

The 0.5 mg amount sits in a low-dose range that may reduce next-day effects. A standard immediate-release capsule supports sleep onset but not sustained overnight delivery.

Study evidence
Melatonin Supportive 181 studies

Ingredients

IngredientAmount per serving
Melatonin
0.5 mg
Gluten Free Adults 18–50
Report overview
Melatonin · 0.5 mg OverallScore64
F Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyC Value

The 0.5 mg amount sits within the range most aligned with natural circadian signaling. Capsule delivery offers standard absorption, but it does not provide sustained release. The average serving cost buys precise low-dose flexibility without premium release technology.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Meta-analysis: melatonin for the treatment of primary sleep disorders.
    Ferracioli-Oda E; Qawasmi A; Bloch MH · PloS one · 2013
    Meta-analysis1,683 participants19 studies pooledSleep Support forMelatonin
  2. Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: A double-blind, randomised clinical trial.
    Sletten TL; Magee M; Murray JM; Gordon CJ; Lovato N; Kennaway DJ; Gwini SM; Bartlett DJ; Lockley SW; Lack LC; Grunstein RR; Rajaratnam SMW; Delayed Sleep on Melatonin (DelSoM) Study Group · PLoS medicine · 2019
    Randomized trial116 participantsSleep Support forMelatonin
  3. Melatonin treatment for age-related insomnia.
    Zhdanova IV; Wurtman RJ; Regan MM; Taylor JA; Shi JP; Leclair OU · The Journal of clinical endocrinology and metabolism · 2001
    Randomized trial30 participantsSleep Support forMelatonin
  4. The Effectiveness of Melatonin for Sleep Disturbances in Parkinson' Disease: Systematic Review and Meta-Analysis.
    Yousef O; Abouelmagd ME; Khaddam H; Shbani A; Yousef R; Meshref M; Hanafi I · Journal of sleep research · 2026
    Meta-analysis409 participants8 studies pooledSleep Support forMelatonin
  5. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.
    Wade AG; Ford I; Crawford G; McConnachie A; Nir T; Laudon M; Zisapel N · BMC medicine · 2010
    Randomized trial791 participantsSleep Support forMelatonin
  6. Effects of exogenous melatonin on sleep: a meta-analysis.
    Brzezinski A; Vangel MG; Wurtman RJ; Norrie G; Zhdanova I; Ben-Shushan A; Ford I · Sleep medicine reviews · 2005
    Meta-analysis284 participants8 studies pooledSleep Support forMelatonin